Prevalence of hepatitis B surface antigen (HBsAg), 2026 methodology in Togo
Togo: Prevalence of hepatitis B surface antigen (HBsAg), 2026 methodology was 1.4% in 2024. ▼ Falling
Prevalence of hepatitis B surface antigen (HBsAg), 2026 methodology in Togo, 2015–2024
Source: United Nations Statistics Division, SDG Global Database.
Analysis
The most recent figure for prevalence of hepatitis b surface antigen (hbsag), 2026 methodology in Togo is 1.4%, measured in 2024. That is the lowest value across all 10 years on record.
That represents a change of down 6.7% on the previous year and down 30.0% over ten years.
Over the whole period, prevalence of hepatitis b surface antigen (hbsag), 2026 methodology in Togo peaked at 2.0% in 2015 and was at its lowest, 1.4%, in 2024.
Togo ranks 20th of 215 countries on this measure, in the top 10%.
Prevalence of hepatitis B surface antigen (HBsAg), 2026 methodology in Togo, year by year
| Year | Value | Change |
|---|---|---|
| 2015 | 2.0% | — |
| 2016 | 2.0% | +0.0% |
| 2017 | 2.0% | +0.0% |
| 2018 | 1.9% | -5.0% |
| 2019 | 1.7% | -10.5% |
| 2020 | 1.7% | +0.0% |
| 2021 | 1.6% | -5.9% |
| 2022 | 1.5% | -6.3% |
| 2023 | 1.5% | +0.0% |
| 2024 | 1.4% | -6.7% |
Averages by decade
| Decade | Average | Lowest | Highest | Years |
|---|---|---|---|---|
| 2010s | 1.9% | 1.7% | 2.0% | 5 |
| 2020s | 1.5% | 1.4% | 1.7% | 5 |
Countries ranked near Togo
- 18 South Sudan 1.7% compare
- 19 Congo 1.6% compare
- 20 Lesotho 1.4% compare
- 20 Mauritania 1.4% compare
- 20 Solomon Islands 1.4% compare
More development goals data for Togo
- Red List Index 0.9285 (2025)
- Number of refugees per 100,000 population, by country of origin 146.03 (2025)
- Manufacturing value added per capita 153.68 (2025)
- Number of transboundary breeds 35 (2025)
- Number of transboundary breeds (not extinct) 35 (2025)
- Number of transboundary breeds with unknown risk status 35 (2025)
- Number of local breeds with unknown risk status 6 (2025)
- Number of local breeds (not extinct) 6 (2025)
- Number of local breeds kept in the country 7 (2025)
- Infant deaths 10,081 (2024)
Frequently asked questions
- What is prevalence of hepatitis b surface antigen (hbsag), 2026 methodology in Togo?
- Prevalence of hepatitis b surface antigen (hbsag), 2026 methodology in Togo was 1.4% in 2024, according to United Nations Statistics Division, SDG Global Database.
- What is the highest prevalence of hepatitis b surface antigen (hbsag), 2026 methodology recorded in Togo?
- The highest recorded value was 2.0% in 2015.
- What is the lowest prevalence of hepatitis b surface antigen (hbsag), 2026 methodology recorded in Togo?
- The lowest recorded value was 1.4% in 2024.
- How does Togo rank for prevalence of hepatitis b surface antigen (hbsag), 2026 methodology?
- Togo ranks 20th out of 215 countries with data for 2024.
- Is prevalence of hepatitis b surface antigen (hbsag), 2026 methodology rising or falling in Togo?
- Over the last ten years it is down 30.0%. The long-run trend across the full record is falling.
- Where does this Togo data come from?
- The figures come from United Nations Statistics Division, SDG Global Database, published as part of Prevalence of hepatitis B surface antigen (HBsAg), 2026 methodology (%). Statizoid updates them automatically from the source API.
Download this data
CSV · JSON — 10 observations, free to reuse under UN SDG Global Database (open, attribution requested).